CDC Updates US Childhood Immunization Schedule to Align with International Standards
Washington, D.C. – In a move responding to a directive from President Trump, the Centers for Disease Control and Prevention (CDC) has updated the U.S. Childhood immunization schedule, aligning it more closely with practices in other developed nations. Acting CDC Director Jim O’Neill formally accepted recommendations stemming from a comprehensive scientific assessment, signaling a shift towards a more focused and transparent approach to childhood vaccinations.
The changes follow a Presidential Memorandum issued December 5, 2025, which called for a review of international best practices. The assessment, and subsequent decision memo signed January 5, 2026, by Deputy Secretary of Health and Human Services Jim O’Neill, aims to strengthen public trust and improve adherence to vaccination schedules.
A Broader Look at Global Practices
The U.S. Has historically recommended a higher number of vaccines and doses for children compared to many other developed countries. The assessment reviewed 20 peer nations and found the U.S. Was an outlier, recommending protection against 18 diseases in 2024, while Denmark, for example, immunizes against 10. Despite the higher number of recommended vaccines, the U.S. Doesn’t demonstrate higher vaccination rates than countries with more streamlined schedules. Many nations achieve strong child health outcomes and high vaccination rates through public trust and education, rather than relying heavily on mandates.
This finding underscores a growing recognition that vaccination rates aren’t solely determined by the number of vaccines offered, but also by factors like parental confidence and clear communication. The assessment highlighted a significant decline in public trust in healthcare institutions between 2020 and 2024, coinciding with falling childhood vaccination rates and an increased risk of vaccine-preventable diseases.
What Changes Are Being Implemented?
The CDC will continue to categorize the childhood immunization schedule into three distinct groups, all covered by insurance without cost-sharing:
- Immunizations Recommended for All Children: This category will include vaccines for measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Haemophilus influenzae type B (Hib), pneumococcal disease, human papillomavirus (HPV), and varicella (chickenpox).
- Immunizations Recommended for Certain High-Risk Groups or Populations: This category will continue to address specific needs based on individual health factors.
- Immunizations Based on Shared Clinical Decision-Making: This category allows for personalized discussions between parents and physicians.
According to Dr. Mehmet Oz, CMS Administrator, “All vaccines currently recommended by CDC will remain covered by insurance without cost sharing. No family will lose access.” The framework aims to empower parents and physicians to make informed decisions based on individual risk profiles, while maintaining robust protection against serious diseases.
The Importance of Transparency and Scientific Rigor
The updated approach emphasizes transparency and a commitment to rigorous scientific evaluation. The assessment calls for more “gold standard” science, including placebo-controlled randomized trials and long-term observational studies, to better understand vaccine benefits, risks, and outcomes. This commitment to evidence-based decision-making is a central tenet of the changes.
Dr. Jay Bhattacharya, National Institutes of Health Director, emphasized this point, stating, “Science demands continuous evaluation. This decision commits NIH, CDC, and FDA to gold standard science, greater transparency, and ongoing reassessment as new data emerge.”
Addressing Declining Public Trust
A key driver behind the schedule update is the need to rebuild public trust in public health institutions. Dr. Marty Makary noted, “Public health works only when people trust it. That trust depends on transparency, rigorous science, and respect for families. This decision recommits HHS to all three.” The changes are intended to foster a more collaborative relationship between healthcare providers, families, and public health agencies.
What Does This Mean for Families?
The updated schedule doesn’t eliminate any currently recommended vaccines, but it aims to clarify recommendations and promote more informed decision-making. Families will continue to have access to all recommended vaccines without cost-sharing. The focus on shared clinical decision-making encourages open conversations between parents and physicians about the risks and benefits of each vaccine, tailored to the child’s individual health status.
Secretary Robert F. Kennedy Jr. Summarized the intent, stating, “After an exhaustive review of the evidence, we are aligning the U.S. Childhood vaccine schedule with international consensus while strengthening transparency and informed consent. This decision protects children, respects families, and rebuilds trust in public health.”
Next Steps: Implementation and Ongoing Evaluation
The HHS and CDC will collaborate with state health agencies, physician groups, and other partners to implement the updated immunization schedules. This will involve educating parents and clinicians about the changes and ensuring a smooth transition. The agencies will also continue to monitor vaccination rates and assess the impact of the updated schedule on child health outcomes. Ongoing surveillance and data analysis will be crucial to inform future adjustments and refinements to the immunization program. Further information can be found on the HHS childhood immunization schedule webpage and in the HHS fact sheet.
The CDC also emphasizes the importance of staying informed about official public health updates and consulting with a qualified healthcare professional for personalized medical advice. You can find more information on the CDC website: https://www.cdc.gov/